Norman Mangner

ORCID: 0000-0003-0793-7923
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Valve Diseases and Treatments
  • Infective Endocarditis Diagnosis and Management
  • Mechanical Circulatory Support Devices
  • Cardiovascular Function and Risk Factors
  • Cardiac Structural Anomalies and Repair
  • Cardiac Arrest and Resuscitation
  • Coronary Interventions and Diagnostics
  • Cardiac Imaging and Diagnostics
  • Cardiovascular and exercise physiology
  • Atrial Fibrillation Management and Outcomes
  • Aortic Disease and Treatment Approaches
  • Muscle Physiology and Disorders
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Acute Myocardial Infarction Research
  • Cardiovascular Effects of Exercise
  • Adipose Tissue and Metabolism
  • Heart Failure Treatment and Management
  • Nutrition and Health in Aging
  • Cardiomyopathy and Myosin Studies
  • Cardiac pacing and defibrillation studies
  • Muscle metabolism and nutrition
  • Exercise and Physiological Responses
  • Antimicrobial Resistance in Staphylococcus
  • Cardiovascular Disease and Adiposity
  • Heart Rate Variability and Autonomic Control

Technische Universität Dresden
2018-2025

University Hospital Carl Gustav Carus
2020-2025

Rigshospitalet
2024

University Medical Center Hamburg-Eppendorf
2024

Aarhus University Hospital
2024

Copenhagen University Hospital
2024

University of Copenhagen
2024

University of Southern Denmark
2024

Universität Hamburg
2024

Heinrich Heine University Düsseldorf
2024

10.1016/s0140-6736(18)31719-7 article EN The Lancet 2018-08-28

Small studies have suggested that high-intensity interval training (HIIT) is superior to moderate continuous (MCT) in reversing cardiac remodeling and increasing aerobic capacity patients with heart failure reduced ejection fraction. The present multicenter trial compared 12 weeks of supervised interventions HIIT, MCT, or a recommendation regular exercise (RRE).Two hundred sixty-one left ventricular fraction ≤35% New York Heart Association class II III were randomly assigned HIIT at 90% 95%...

10.1161/circulationaha.116.022924 article EN cc-by-nc-nd Circulation 2017-01-13

<h3>Importance</h3> Stroke remains a major predictor of mortality after transcatheter aortic valve implantation (TAVI). Cerebral protection devices might reduce brain injury as determined by diffusion-weighted magnetic resonance imaging (DWMRI). <h3>Objective</h3> To determine the effect cerebral device on number and volume lesions in patients undergoing TAVI. <h3>Design, Setting, Participants</h3> Investigator-initiated, single center, blinded, randomized clinical trial higher-risk with...

10.1001/jama.2016.10302 article EN JAMA 2016-08-09

Remote ischaemic conditioning (RIC) and postconditioning (PostC) are both potent activators of innate protection against ischaemia-reperfusion injury have demonstrated cardioprotection in experimental clinical ST-elevation myocardial infarction (STEMI) trials. However, their combined effects not been studied detail. The aim this study was to evaluate if the co-application intrahospital RIC PostC has a more powerful effect on salvage compared with either alone or control.This prospective,...

10.1093/eurheartj/ehv463 article EN European Heart Journal 2015-09-17

10.1016/s0140-6736(20)32173-5 article EN The Lancet 2020-10-19

In patients with ST-segment elevation myocardial infarction (STEMI) multivessel coronary artery disease, the time at which complete revascularization of nonculprit lesions should be performed remains unknown. Download a PDF Research Summary. We an international, open-label, randomized, noninferiority trial 37 sites in Europe. Patients hemodynamically stable condition who had STEMI and disease were randomly assigned to undergo immediate percutaneous intervention (PCI; group) or PCI culprit...

10.1056/nejmoa2307823 article EN New England Journal of Medicine 2023-08-27
Andreas Baumbach Niels van Royen Ignacio J. Amat‐Santos Martin Hudec Matjaž Bunc and 95 more Alexander Ijsselmuiden Peep Laanmets Daniel Unić Béla Merkely Renicus S. Hermanides Vlasis Ninios Marcin Protasiewicz Benno J. Rensing Pedro Martín Fausto Feres Manuel Almeida Éric Van Belle Axel Linke Alfonso Ielasi Matteo Montorfano Mark Webster Konstantinos Toutouzas Emmanuel Teíger Francesco Bedogni Michiel Voskuil Manuel Pan Oskar Angerås Won‐Keun Kim Jürgen Rothe Ivica Kristić Vicente Peral Scot Garg Hesham Elzomor Akihiro Tobe Marie‐Claude Morice Yoshinobu Onuma Osama Soliman Patrick W. Serruys Dimytri Siqueira Ibraim Pinto Alberto Cervone Jorge Eduardo Assef Andréa Andrade Vilela A. Paladino Auristela Ramos Mariana T. Rezende Samira Kaissar Ghorayeb Tacianne Rolemberg Braga Silva Savica Gjorgjievska Irzal Hadžibegović Ivana Jurin Tomislav Šipić Nikola Pavlović Igor Rudež Šime Manola Romain Gallet Madjid Boukantar Eroan Nicolas Pierre Valdimir ENNEZAT Jean Marie Urien Flavien Vincent Cédric Delhaye Tom Denimal Alessandro Cosenza Thibault Pamart Sina Porouchani François Pontana David Montaigne Vincent Balmette Mohamed Yahya Bechiri Elisabeth Chen Dany Janah Matthias Renker Dirk Westermann Christian Valina Mirosław Ferenc Nikolaus Löffelhardt Faridun Rahimi Philipp Breitbart Kilian Franke Martin Czerny Nawras Diab Peter Sick Medea Adeishvili Norman Mangner Stephan Haußig Krunuslav Sveric Lisa Crusius Marie Roehlig Leonidas Koliastasis Maria Drakopoulou Odysseas Katsaros Nikolaos Ktenopoulos Andreas Ioanniadis Sotirios Evangelou Ilias Ninios Levente Molnár Roland Papp Ferencz Arnold-Béla Orsolya Kiss

10.1016/s0140-6736(24)00821-3 article EN The Lancet 2024-05-22

Background— Muscle wasting occurs in both chronic heart failure (CHF) and normal aging contributes to exercise intolerance increased morbidity/mortality. However, the molecular mechanisms of muscle atrophy CHF their interaction with are still largely unknown. We therefore measured activation ubiquitin-proteasome system lysosomal pathway intracellular proteolysis biopsies patients healthy controls two age strata assessed age-dependent effects a 4-week endurance training program on...

10.1161/circulationaha.111.047381 article EN Circulation 2012-05-08

A reduction in number and function of endothelial progenitor cells (EPCs) occurs both physiologic aging chronic heart failure (CHF). We assessed whether disease have additive effects on EPCs or beneficial exercise training are diminished old age. randomized 60 patients with stable CHF referent controls to a control group. To detect possible we included subjects below 55 (young) above 65 years (older). Subjects the group exercised four times daily at 60% 70% VO2max for weeks under...

10.1177/2047487315588391 article EN European Journal of Preventive Cardiology 2015-05-26

Chronic heart failure (CHF) is commonly associated with muscle atrophy and increased inflammation. Irisin, a myokine proteolytically processed by the fibronectin type III domain containing 5 (FNDC5) gene suggested to be Peroxisome proliferator-activated receptor gamma coactivator (PGC)-1α activated, modulates browning of adipocytes related mass. Therefore, we investigated whether skeletal FNDC5 expression in CHF was reduced if this mediated inflammatory cytokines and/or angiotensin II...

10.1002/jcsm.12006 article EN cc-by-nc-nd Journal of Cachexia Sarcopenia and Muscle 2015-03-01

A well-developed coronary collateral circulation provides a potential source of blood supply in artery disease. However, the prognostic importance and functional relevance collaterals is controversial with association between exercise training growth still unclear.This prospective, open-label study randomly assigned 60 patients significant disease (fractional flow reserve ≤0.75) to high-intensity (group A, 20 patients) or moderate-intensity B, for 4 weeks control group C, patients). The...

10.1161/circulationaha.115.016442 article EN Circulation 2016-04-11

Abstract Background Muscle ring finger 1 (MuRF1) is a muscle‐specific ubiquitin E3 ligase activated during clinical conditions associated with skeletal muscle wasting. Yet, there remains paucity of therapeutic interventions that directly inhibit MuRF1 function, particularly in vivo . The current study, therefore, developed novel compound targeting the central coiled coil domain to wasting cardiac cachexia. Methods We identified small molecules interfere MuRF1–titin interaction from 130 000...

10.1002/jcsm.12233 article EN cc-by-nc-nd Journal of Cachexia Sarcopenia and Muscle 2017-09-08

Background: Patients at high-bleeding risk (HBR) undergoing percutaneous coronary intervention represent a challenging patient population. The use of drug-coated balloon (DCB) allows shorter duration dual antiplatelet therapy compared with drug-eluting stents (DES) and reduces thrombotic due to the absence permanent implant. present analysis aimed investigate if effect DCB versus DES differed between patients without HBR treated in small arteries. Methods: This prespecified subgroup...

10.1161/circinterventions.121.011569 article EN Circulation Cardiovascular Interventions 2022-04-01

Despite its high incidence and mortality risk, there is no evidence-based treatment for non-ischaemic cardiogenic shock (CS). The aim of this study was to evaluate the use mechanical circulatory support (MCS) CS treatment.In multicentre, international, retrospective study, data from 890 patients with CS, defined as due severe de-novo or acute-on-chronic heart failure need urgent revascularization, treated without active MCS, were collected. association between MCS primary endpoint 30-day...

10.1002/ejhf.2796 article EN cc-by-nc European Journal of Heart Failure 2023-02-14

Background: In the Danish–German Cardiogenic Shock (DanGer Shock) trial, use of a microaxial flow pump (mAFP) in patients with ST-segment elevation myocardial infarction (STEMI)-related CS led to lower all-cause mortality but higher rates renal replacement therapy (RRT). this prespecified analysis, and predictors acute kidney injury (AKI) RRT were assessed. Methods: international, randomized, open label, multicenter 355 adult STEMI-CS randomized mAFP (N=179) or standard care alone (N=176)....

10.1161/circulationaha.124.072370 article EN Circulation 2024-10-27
Coming Soon ...